Skip to main content
. 2022 May 24;9:895927. doi: 10.3389/fmolb.2022.895927

FIGURE 5.

FIGURE 5

Construction and performance validation of the lncRNA-AP000695.2-based nomogram for lung adenocarcinoma patients. (A–D) Nomogram to predict the overall survival, disease-free survival, and progression-free survival of lung cancer patients, and the calibration curve and Hosmer–Lemeshow test of nomograms in TCGA-lung adenocarcinoma cohort for overall survival, disease-specific survival, and progression-free survival.